| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Vireo Growth Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.60 |
| 52 Week High | CA$0.95 |
| 52 Week Low | CA$0.14 |
| Beta | 1.42 |
| 11 Month Change | -4.76% |
| 3 Month Change | 5.26% |
| 1 Year Change | 207.69% |
| 33 Year Change | -71.56% |
| 5 Year Change | -79.31% |
| Change since IPO | -88.00% |
Recent News & Updates
Recent updates
Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost
Jun 01
Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company
Apr 06Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump
Feb 01Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt
Dec 14Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?
Jul 14Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?
Mar 19Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?
Jan 25Vireo Health International's (CSE:VREO) Shareholders Are Down 55% On Their Shares
Sep 04Shareholder Returns
| VREO | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -0.5% | 0.03% |
| 1Y | 207.7% | 36.6% | 10.3% |
Return vs Industry: VREO exceeded the Canadian Pharmaceuticals industry which returned 36.6% over the past year.
Return vs Market: VREO exceeded the Canadian Market which returned 10.3% over the past year.
Price Volatility
| VREO volatility | |
|---|---|
| VREO Average Weekly Movement | 17.6% |
| Pharmaceuticals Industry Average Movement | 12.5% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CA Market | 16.8% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: VREO's share price has been volatile over the past 3 months.
Volatility Over Time: VREO's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 438 | Josh Rosen | vireohealth.com |
Vireo Growth Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York.
Vireo Growth Inc. Fundamentals Summary
| VREO fundamental statistics | |
|---|---|
| Market cap | CA$88.01m |
| Earnings (TTM) | -CA$32.75m |
| Revenue (TTM) | CA$127.88m |
0.7x
P/S Ratio-2.7x
P/E RatioIs VREO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VREO income statement (TTM) | |
|---|---|
| Revenue | US$93.13m |
| Cost of Revenue | US$46.30m |
| Gross Profit | US$46.83m |
| Other Expenses | US$70.68m |
| Earnings | -US$23.85m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.16 |
| Gross Margin | 50.28% |
| Net Profit Margin | -25.61% |
| Debt/Equity Ratio | -311.4% |
How did VREO perform over the long term?
See historical performance and comparison